Leap Investments’s Enzo Biochem, Inc. ENZ Stock Holding History

Leap Investments’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-11,811	Closed	-$40K	–	508
2019 Q2	$40K	Buy	+11,811	New	+$41.6K	0.05%	235

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Leap Investments's ENZ Position: Q3 2019 in Review

Leap Investments sold out of Enzo Biochem, Inc. (ENZ) in Q3 2019, closing a stake of 11,811 shares — an estimated $40K sold.

Leap Investments first reported a position in ENZ in Q2 2019 and held it in 1 quarter. The position peaked at $40K in Q2 2019. 87 funds tracked by Wall St. Rank hold ENZ as of Q3 2019.

Leap Investments reported no remaining Enzo Biochem, Inc. position as of Q3 2019 after selling out during the quarter.
Leap Investments sold 11,811 Enzo Biochem, Inc. shares in Q3 2019, an estimated $40K.
Leap Investments first reported a position in Enzo Biochem, Inc. in Q2 2019 and held it in 1 quarter.
Leap Investments's Enzo Biochem, Inc. position peaked at $40K in Q2 2019.
87 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2019.

Based on Leap Investments's 13F filing for Q3 2019, filed 13 Nov 2019.